Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2D Ultrasound Elasticity Imaging of Abdominal Aortic Aneurysms Using Deep Neural Networks.

IEEE transactions on computational imaging·2026
Same author

Toward Patient-Specific Partial Point Cloud to Surface Completion for Pre to Intra-operative Registration in Image-Guided Liver Interventions.

Medical Image Understanding and Analysis. Medical Image Understanding and Analysis (Conference)·2026
Same author

Evaluation of Intra-operative Patient-specific Methods for Point Cloud Completion for Minimally Invasive Liver Interventions.

Proceedings of SPIE--the International Society for Optical Engineering·2026
Same author

Investigating the Domain Adaptability of General-Purpose Foundation Models for Left Atrium Segmentation from MR Images.

Functional imaging and modeling of the heart : ... International Workshop, FIMH ..., proceedings. FIMH (Conference)·2026
Same author

Assessing the Performance of the DINOv2 Self-supervised Learning Vision Transformer Model for the Segmentation of the Left Atrium from MRI Images.

Proceedings of SPIE--the International Society for Optical Engineering·2026
Same author

Percutaneous renal mass biopsies with no viable lesional cells - Recognizing different histologic patterns can help predict nondiagnostic vs. true negative biopsy and guide clinical management.

Annals of diagnostic pathology·2026

Related Experiment Video

Updated: Feb 24, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K

Inference for multimarker adaptive enrichment trials.

Richard Simon1, Noah Simon2

  • 1Biometric Research Program, National Cancer Institute, Rockville, MD 20850, USA.

Statistics in Medicine
|August 11, 2017
PubMed
Summary
This summary is machine-generated.

Adaptive enrichment designs in cancer trials help identify patient subgroups likely to benefit from new treatments. This study addresses key inference issues for these flexible trial designs, improving biomarker-driven drug development.

Keywords:
adaptive clinical trialsbiomarkerenrichmentresampling

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
12:11

Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization

Published on: February 27, 2020

7.3K

Related Experiment Videos

Last Updated: Feb 24, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
12:11

Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization

Published on: February 27, 2020

7.3K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Cancer Drug Development

Background:

  • Identifying treatment selection biomarkers is crucial for personalized cancer therapy.
  • Adaptive enrichment designs offer flexibility when a single biomarker isn't clear.
  • These designs allow modification of patient eligibility at interim analyses.

Purpose of the Study:

  • To address inference challenges in adaptive enrichment trial designs.
  • To define the intended use population and estimate treatment effects post-trial.
  • To establish conditions under which strong null hypothesis rejection implies intended use population null hypothesis rejection.

Main Methods:

  • Utilizing a flexible approach for model-based multifeature predictive classifiers and continuous biomarker cut-points.
  • Performing a single significance test on all randomized patients against the strong null hypothesis.
  • Analyzing two key inference issues following adaptive enrichment design.

Main Results:

  • The study focuses on the inferential framework for adaptive enrichment designs.
  • It proposes methods for defining the intended use population and estimating treatment effects.
  • Conditions for hypothesis testing are explored within this adaptive framework.

Conclusions:

  • The proposed methods enhance the inferential capabilities of adaptive enrichment designs.
  • This work supports robust biomarker-driven cancer drug development.
  • It provides a framework for making valid conclusions about treatment efficacy in specific patient populations.